We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc. (RLAY)’s share was trading at $3.15 as of May 6th.
A doctor consulting with a patient, discussing treatment options for breast cancer.
Relay Therapeutics (RLAY) is taking decisive steps to secure its future by doubling down on its lead program, RLY-2608, while implementing aggressive cost control measures to...
